| (AUD) | Jun 2017 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -1.77M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CYP.AX returned -94.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -96.8% |
| 1 year | -94.2% |
| 5 years | -97.9% |
| 10 years | -97.0% |
| All-time high | $3.39 (Sep 2009) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CYP.AX would be worth today ›No. Cynata Therapeutics Limited has not paid a dividend in the past 12 months.
Cynata Therapeutics Limited is part of the Healthcare sector.
Cynata Therapeutics Limited has a market cap of 2.68M AUD, based on the latest quote.